Si-Bone Inc (NASDAQ:SIBN) — Market Cap & Net Worth
Market Cap & Net Worth: Si-Bone Inc (SIBN)
Si-Bone Inc (NASDAQ:SIBN) has a market capitalization of $808.53 Million ($808.53 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9909 globally and #2698 in its home market, demonstrating a -2.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Si-Bone Inc's stock price $18.04 by its total outstanding shares 44818575 (44.82 Million). Also see Si-Bone Inc total assets for a full breakdown of the balance sheet.
Si-Bone Inc Market Cap History: 2018 to 2026
Si-Bone Inc's market capitalization history from 2018 to 2026. Data shows change from $936.26 Million to $808.53 Million (-1.33% CAGR). Also see Si-Bone Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Si-Bone Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.03% | #282 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1035 of 3165 |
Weight: Si-Bone Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Si-Bone Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Si-Bone Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SIBN stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.40x
Si-Bone Inc's market cap is 4.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $936.26 Million | $55.38 Million | -$17.45 Million | 16.91x | N/A |
| 2019 | $963.60 Million | $67.30 Million | -$38.40 Million | 14.32x | N/A |
| 2020 | $1.34 Billion | $73.39 Million | -$43.70 Million | 18.26x | N/A |
| 2021 | $995.42 Million | $90.15 Million | -$56.57 Million | 11.04x | N/A |
| 2022 | $609.53 Million | $106.41 Million | -$61.26 Million | 5.73x | N/A |
| 2023 | $940.74 Million | $138.89 Million | -$43.34 Million | 6.77x | N/A |
| 2024 | $628.36 Million | $167.18 Million | -$30.91 Million | 3.76x | N/A |
| 2025 | $883.82 Million | $200.93 Million | -$18.91 Million | 4.40x | N/A |
Competitor Companies of SIBN by Market Capitalization
Companies near Si-Bone Inc in the global market cap rankings as of September 18, 2026. Review tangible equity quality of Si-Bone Inc to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Si-Bone Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Si-Bone Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, Si-Bone Inc's market cap moved from $936.26 Million to $ 808.53 Million, with a yearly change of -1.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $808.53 Million | -8.52% |
| 2025 | $883.82 Million | +40.66% |
| 2024 | $628.36 Million | -33.21% |
| 2023 | $940.74 Million | +54.34% |
| 2022 | $609.53 Million | -38.77% |
| 2021 | $995.42 Million | -25.72% |
| 2020 | $1.34 Billion | +39.07% |
| 2019 | $963.60 Million | +2.92% |
| 2018 | $936.26 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Si-Bone Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $808.53 Million USD |
| MoneyControl | $808.53 Million USD |
| MarketWatch | $808.53 Million USD |
| marketcap.company | $808.53 Million USD |
| Reuters | $808.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more